18 October 2013 - Deborah Wilkes
Archived
Celesio's majority shareholder, Haniel, is refusing to comment on press reports that US drug distributor McKesson is in "advanced talks" to buy Celesio.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.